Literature DB >> 30968109

The culprit is the carrier, not the loads: cholesterol, triglycerides and apolipoprotein B in atherosclerosis and coronary heart disease.

Mika Ala-Korpela1,2,3,4,5,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30968109     DOI： 10.1093/ije/dyz068

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN： 0300-5771            Impact factor:   7.196


× No keyword cloud information.
  14 in total

1.  Apt interpretation of comprehensive lipoprotein data in large-scale epidemiology: disclosure of fundamental structural and metabolic relationships.

Authors:  Mika Ala-Korpela; Siyu Zhao; Marjo-Riitta Järvelin; Ville-Petteri Mäkinen; Pauli Ohukainen
Journal:  Int J Epidemiol       Date:  2022-06-13       Impact factor: 9.685

2.  High-throughput multivariable Mendelian randomization analysis prioritizes apolipoprotein B as key lipid risk factor for coronary artery disease.

Authors:  Verena Zuber; Dipender Gill; Mika Ala-Korpela; Claudia Langenberg; Adam Butterworth; Leonardo Bottolo; Stephen Burgess
Journal:  Int J Epidemiol       Date:  2021-07-09       Impact factor: 7.196

3.  Commentary: Big data bring big controversies: HDL cholesterol and mortality.

Authors:  Mika Ala-Korpela; Sanna Kuusisto; Michael V Holmes
Journal:  Int J Epidemiol       Date:  2021-07-09       Impact factor: 7.196

Review 4.  Natural Drugs as a Treatment Strategy for Cardiovascular Disease through the Regulation of Oxidative Stress.

Authors:  Xing Chang; Tian Zhang; Wenjin Zhang; Zhenyu Zhao; Jiahui Sun
Journal:  Oxid Med Cell Longev       Date:  2020-09-27       Impact factor: 6.543

5.  Body muscle gain and markers of cardiovascular disease susceptibility in young adulthood: A cohort study.

Authors:  Joshua A Bell; Kaitlin H Wade; Linda M O'Keeffe; David Carslake; Emma E Vincent; Michael V Holmes; Nicholas J Timpson; George Davey Smith
Journal:  PLoS Med       Date:  2021-09-09       Impact factor: 11.069

Review 6.  Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations.

Authors:  Li-Chan Tao; Jia-Ni Xu; Ting-Ting Wang; Fei Hua; Jian-Jun Li
Journal:  Cardiovasc Diabetol       Date:  2022-05-06       Impact factor: 8.949

7.  Circulating Lipoprotein Lipids, Apolipoproteins and Ischemic Stroke.

Authors:  Shuai Yuan; Bowen Tang; Jie Zheng; Susanna C Larsson
Journal:  Ann Neurol       Date:  2020-10-10       Impact factor: 10.422

8.  Associations of lipoprotein particle profile and objectively measured physical activity and sedentary time in schoolchildren: a prospective cohort study.

Authors:  Paul Remy Jones; Tarja Rajalahti; Geir Kåre Resaland; Eivind Aadland; Jostein Steene-Johannessen; Sigmund Alfred Anderssen; Tone Frost Bathen; Trygve Andreassen; Olav Martin Kvalheim; Ulf Ekelund
Journal:  Int J Behav Nutr Phys Act       Date:  2022-01-21       Impact factor: 6.457

9.  Vexed causal inferences in nutritional epidemiology-call for genetic help.

Authors:  Pauli Ohukainen; Jyrki K Virtanen; Mika Ala-Korpela
Journal:  Int J Epidemiol       Date:  2022-02-18       Impact factor: 7.196

10.  Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis.

Authors:  Tom G Richardson; Eleanor Sanderson; Tom M Palmer; Mika Ala-Korpela; Brian A Ference; George Davey Smith; Michael V Holmes
Journal:  PLoS Med       Date:  2020-03-23       Impact factor: 11.069
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.